danazol has been researched along with tamoxifen in 74 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 29 (39.19) | 18.7374 |
1990's | 20 (27.03) | 18.2507 |
2000's | 14 (18.92) | 29.6817 |
2010's | 11 (14.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bergström, CA; Hubatsch, I; Johansson, K; Wassvik, CM | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Freiwald, S; Jiang, Y; Jones, JP; Kaspera, R; Katayama, J; Lee, CA; Smith, E; Totah, RA; Walker, GS | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Purohit, A; Reed, MJ | 1 |
Contesso, G; Scali, P | 1 |
Gateley, CA; Mansel, RE | 1 |
Ashley, SE; Coombes, RC; Ellin, CL; Hardy, JR; Judson, IR; Powles, TJ; Sinnett, HD | 1 |
Büchner, T; Hiddemann, W; Koenigsmann, M; Wörmann, B; Zühlsdorf, M | 1 |
Fekete, S; Gráf, F; Raposa, T; Várkonyi, J | 1 |
Fersizoglou, N; Junkermann, H; Krapfe, E; Stolz, W; von Fournier, D; Weber, E | 1 |
Stein, RS | 1 |
Soh, E | 1 |
Sagar, SM | 1 |
Büchner, T; Hiddemann, W; Van de Loo, J; Volkenandt, M | 1 |
Carlström, K; Pousette, A; Rannevik, G; Sköldefors, H; Theve, NO; Wilking, N | 1 |
Bagley, C; Lippman, ME; Steinberg, SM; Swain, SM | 1 |
Angeli, A; Dogliotti, L; Fioretti, P; Melis, GB; Mussa, A | 1 |
Nilsson, B; Ottosson, UB; Södergård, R; von Schoultz, B | 1 |
Scott, EB | 1 |
Mainenti, M; Silvestre, V; Zacché, G; Zanoio, L | 1 |
Büchner, T; Göhde, W; Hiddemann, W; Wörmann, B | 1 |
Benz, C; Hollander, C; Miller, B | 1 |
Coombes, RC; Easton, D; Goss, PE; Singh, D; Wilkinson, JR; Williams, JC | 1 |
Lutz, D | 1 |
Grisold, W; Lutz, D; Mamoli, B; Mokrusa, W; Weber, R | 1 |
Friedman, D; Netti, F; Schreiber, AD | 1 |
Achterrath, W; Balleisen, L; Büchner, T; Hiddemann, W; Preusser, P; Urbanitz, D | 1 |
Ashley, S; Coombes, RC; Ford, HT; Gazet, JC; Nash, AG; Neville, AM; Powles, TJ | 1 |
Ingle, JN | 1 |
Carlström, K; Döberl, A; Pousette, A; Rannevik, G; Wilking, N | 1 |
Bauer, KH; Bettendorf, U; Kaiser, E | 1 |
Coombes, RC; Dowsett, M; Harris, AL; Jeffcoate, SL; McGarrick, GE; Smith, IE | 1 |
Coombes, RC; Dady, P; Ford, HT; Gazet, JC; McCready, VR; Parsons, C; Powles, TJ | 1 |
Goldstein, PJ; London, RS; Sundaram, GS | 1 |
Coombes, RC; Gordon, C; Powles, TJ | 1 |
Abbott, M; Coombes, RC; Jones, JM; Powles, TJ; Rowland-Payne, CM | 1 |
Coombes, RC; Ford, HT; Gazet, JC; Henk, M; Nash, AG; Neville, AM; Powles, TJ; Ratcliffe, WA; Rees, LH | 1 |
Fujimoto, J; Hori, M; Ichigo, S; Morishita, S; Tamaya, T | 1 |
Cech, E; Smejkal, V; Strnad, P; Vachousek, J; Velek, J | 1 |
Stalfelt, AM | 1 |
Haase, D; Hehlmann, R; Hild, F; Lengfelder, E; Simon, M | 1 |
Dengler, R; Emmerich, B; Walther, JU | 1 |
Sugimura, M; Terao, T | 1 |
Wetzig, NR | 1 |
Bhowal, AK; Bishop, JF; Drummond, RM; Jeal, PN; Murray, R; Olver, IN; Pitt, P; Smith, JG | 1 |
Alford, WS; Hopkins, MP | 1 |
Rodriguez, JL; Steinbrunn, BS; Zera, RT | 1 |
Kontostolis, E; Lolis, D; Navrozoglou, I; Stefanidis, K | 1 |
Doğan, E; Erten, O; Saygili, U; Uslu, T; Yörükoğlu, K | 1 |
Busch, R; Dengler, R; Eger, G; Emmerich, B; Münstermann, U; Plewan, A | 1 |
Diehl, V; Dimski, T; Lathan, B; Pantke, B; Schinköthe, T; Staib, P; Voliotis, D; Wiedenmann, S | 1 |
Chow, LW; Leung, YF; Ting, AC | 1 |
Faiz, O; Fentiman, IS | 1 |
Bundred, N | 6 |
Chavanu, KJ; O'Donnell, DC | 1 |
Goetz, M; Heussel, H; Hiddemann, W; Schiel, X; Steinmetz, T; Weiss, M | 1 |
Arvind, N; Chabra, A; Dhar, A; Mansel, RE; Prasad, K; Srivastava, A | 1 |
Haferlach, C; Haferlach, T; Schnittger, S; Weisser, M | 1 |
Aul, C; Balleisen, L; Beelen, D; Berdel, WE; Braess, J; Büchner, T; Eimermacher, H; Gale, RP; Giagounidis, A; Görlich, D; Grüneisen, A; Haferlach, C; Haferlach, T; Hehlmann, R; Heinecke, A; Hiddemann, W; Kern, W; Köpcke, W; Krug, U; Lengfelder, E; Ludwig, WD; Maschmeyer, G; Müller-Tidow, C; Rasche, H; Reichle, A; Sauerland, MC; Schliemann, C; Schnittger, S; Serve, H; Spiekermann, K; Staib, P; Stelljes, M; Thiel, E; Wörmann, BJ | 1 |
18 review(s) available for danazol and tamoxifen
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Hyperplastic lesions of the high risk breast. Definitions, diagnostic and therapeutic problems].
Topics: Biopsy; Breast Neoplasms; Danazol; Female; Fibrocystic Breast Disease; Humans; Hyperplasia; Incidence; Mass Screening; Mastectomy; Menopause; Population Surveillance; Risk Factors; Tamoxifen | 1992 |
Advances in the therapy of acute nonlymphocytic leukemia.
Topics: Aminoglutethimide; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Danazol; Humans; Leukemia, Myeloid, Acute; Tamoxifen | 1989 |
Fibrocystic breast disease.
Topics: Adult; Breast; Bromocriptine; Danazol; Female; Fibrocystic Breast Disease; Humans; Mammography; Middle Aged; Nutritional Physiological Phenomena; Palpation; Tamoxifen | 1987 |
[Update in the therapy of fibrocystic mastopathy].
Topics: Bromocriptine; Danazol; Endocrine System Diseases; Female; Fibrocystic Breast Disease; Humans; Pregnadienes; Progestins; Tamoxifen | 1987 |
Medical management of mammary dysplasia.
Topics: Breast Diseases; Danazol; Diuretics; Female; Fibrocystic Breast Disease; Gonadal Steroid Hormones; Humans; Tamoxifen; Thyroid Hormones; Vitamins; Xanthines | 1982 |
[Hormonal treatment of non-malignant diseases of the breast].
Topics: Breast Diseases; Danazol; Female; Gonadotropin-Releasing Hormone; Hormones; Humans; Progestins; Tamoxifen | 1995 |
[Antiestrogen therapy of patients with uterine cancer].
Topics: Danazol; Estrogen Antagonists; Female; Humans; Medroxyprogesterone Acetate; Tamoxifen; Uterine Neoplasms | 1994 |
Mastalgia. Tailoring treatment to type of breast pain.
Topics: Breast; Breast Neoplasms; Bromocriptine; Danazol; Fatty Acids, Essential; Female; gamma-Linolenic Acid; Hormone Antagonists; Humans; Linoleic Acids; Oenothera biennis; Pain; Plant Oils; Risk Factors; Tamoxifen | 1997 |
Management of breast pain.
Topics: Breast Diseases; Bromocriptine; Danazol; Estrogen Antagonists; Female; Hormone Antagonists; Humans; Pain; Progesterone; Tamoxifen | 2000 |
Breast pain.
Topics: Breast; Danazol; Diet, Fat-Restricted; Female; Gestrinone; Humans; Pain; Randomized Controlled Trials as Topic; Tamoxifen; Treatment Outcome | 2002 |
Hormonal interventions for menstrual migraines.
Topics: Clinical Trials as Topic; Danazol; Estradiol; Female; Hormones; Humans; Menstrual Cycle; Migraine Disorders; Tamoxifen | 2002 |
Breast pain.
Topics: Breast; Danazol; Diet, Fat-Restricted; Female; Gestrinone; Humans; Pain; Tamoxifen | 2002 |
Breast pain.
Topics: Breast; Danazol; Diet, Fat-Restricted; Female; Hormone Replacement Therapy; Humans; Pain; Tamoxifen | 2003 |
Breast pain.
Topics: Breast; Danazol; Diet, Fat-Restricted; Female; Hormone Replacement Therapy; Humans; Pain; Tamoxifen | 2004 |
Breast pain.
Topics: Breast; Danazol; Estrogen Antagonists; Female; Hormone Replacement Therapy; Humans; Pain; Tamoxifen | 2005 |
Breast pain.
Topics: Breast; Danazol; Estrogen Antagonists; Female; Hormone Replacement Therapy; Humans; Pain; Tamoxifen | 2005 |
Evidence-based management of Mastalgia: a meta-analysis of randomised trials.
Topics: Breast Diseases; Bromocriptine; Danazol; Estrogen Antagonists; Female; Humans; Pain; Pain Measurement; Phytotherapy; Plant Oils; Primula; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen | 2007 |
10 trial(s) available for danazol and tamoxifen
Article | Year |
---|---|
Tamoxifen and fluoxymesterone versus tamoxifen and danazol in metastatic breast cancer--a randomized study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Danazol; Female; Fluoxymesterone; Humans; Menopause; Middle Aged; Random Allocation; Tamoxifen | 1988 |
Treatment of disseminated breast cancer with tamoxifen, aminoglutethimide, hydrocortisone, and danazol, used in combination or sequentially.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Danazol; Female; Humans; Hydrocortisone; Menopause; Receptors, Estrogen; Tamoxifen | 1984 |
Additive hormonal therapy in women with advanced breast cancer.
Topics: Aminoglutethimide; Androgens; Breast Neoplasms; Clinical Trials as Topic; Danazol; Drug Therapy, Combination; Estrogens; Female; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Humans; Hypophysectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Random Allocation; Tamoxifen | 1984 |
Clinical trial of multiple endocrine therapy for metastatic and locally advanced breast cancer with tamoxifen-aminoglutethimide-danazol compared to tamoxifen used alone.
Topics: Aminoglutethimide; Breast Neoplasms; Clinical Trials as Topic; Danazol; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Pregnadienes; Probability; Random Allocation; Tamoxifen | 1982 |
Quality of life during induction treatment of acute myeloid leukaemia. A comparison of three intensive chemotherapy regimens using three instruments for quality of life assessment.
Topics: Acute Disease; Adolescent; Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Danazol; Female; Humans; Interviews as Topic; Karnofsky Performance Status; Leukemia, Myeloid; Longitudinal Studies; Male; Methods; Middle Aged; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic; Surveys and Questionnaires; Tamoxifen | 1994 |
The effect of danazol on tumour control and weight loss in patients on tamoxifen therapy for advanced breast cancer: a randomised double-blind placebo controlled trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Danazol; Double-Blind Method; Female; Humans; Middle Aged; Placebos; Prognosis; Receptors, Estrogen; Tamoxifen; Weight Loss | 1993 |
Comparison of tamoxifen with danazol for treatment of cyclical mastalgia.
Topics: Adult; Cohort Studies; Danazol; Estrogen Antagonists; Female; Humans; Pain; Premenstrual Syndrome; Prospective Studies; Reference Values; Tamoxifen | 1997 |
Prognosis in adult AML is precisely predicted by the DISC-assay using the chemosensitivity-index Ci.
Topics: Adult; Aminoglutethimide; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cell Survival; Cytarabine; Danazol; Drug Screening Assays, Antitumor; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Leukemia, Myeloid, Acute; Predictive Value of Tests; Prognosis; Prospective Studies; Regression Analysis; Remission Induction; Survival Analysis; Tamoxifen; Vidarabine | 1999 |
Elevation of soluble tumor necrosis factor receptor II in non-febrile patients with acute myeloid leukemia.
Topics: Adult; Aged; Aminoglutethimide; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Danazol; Etanercept; Female; Fever; Humans; Immunoglobulin G; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Neutropenia; Prospective Studies; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type II; Tamoxifen | 2002 |
Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia.
Topics: Adult; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Danazol; Disease-Free Survival; Granulocyte Colony-Stimulating Factor; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Middle Aged; Mitoxantrone; Stem Cell Transplantation; Survival Rate; Tamoxifen; Transplantation, Autologous; Treatment Outcome; Young Adult | 2016 |
46 other study(ies) available for danazol and tamoxifen
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Poorly soluble marketed drugs display solvation limited solubility.
Topics: Calorimetry, Differential Scanning; Chemical Phenomena; Chemistry, Physical; Chromatography, High Pressure Liquid; Molecular Structure; Multivariate Analysis; Pharmaceutical Preparations; Principal Component Analysis; Solubility; Tandem Mass Spectrometry; Thermodynamics | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
Topics: Amiodarone; Astemizole; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Danazol; Drug Discovery; Drug Interactions; Enzyme Inhibitors; Humans; Hydroxylation; In Vitro Techniques; Methylation; Microsomes, Liver; Models, Biological; Molecular Structure; Substrate Specificity; Tandem Mass Spectrometry; Terfenadine | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Cyclical breast pain--what works and what doesn't.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Breast Diseases; Bromocriptine; Danazol; Fatty Acids, Essential; Female; gamma-Linolenic Acid; Goserelin; Humans; Linoleic Acids; Oenothera biennis; Pain; Periodicity; Plant Oils; Premenstrual Syndrome; Tamoxifen | 1992 |
Oestrogen sulphatase activity in hormone-dependent and hormone-independent breast-cancer cells: modulation by steroidal and non-steroidal therapeutic agents.
Topics: Breast Neoplasms; Cell Division; Danazol; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Ethinyl Estradiol; Female; Humans; Kinetics; Receptors, Estrogen; Receptors, Progesterone; Sulfatases; Tamoxifen; Tumor Cells, Cultured | 1992 |
Management of the painful and nodular breast.
Topics: Adult; Age Factors; Breast Diseases; Bromocriptine; Buserelin; Danazol; Estrogen Replacement Therapy; Fatty Acids, Essential; Female; gamma-Linolenic Acid; Goserelin; Humans; Hypolipidemic Agents; Linoleic Acids; Oenothera biennis; Pain; Plant Oils; Tamoxifen | 1991 |
Combination of tamoxifen, aminoglutethimide, danazol and medroxyprogesterone acetate in advanced breast cancer.
Topics: Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Danazol; Female; Humans; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Tamoxifen | 1990 |
Changing response of clonogenic myeloid leukemia blasts to granulocyte-macrophage colony-stimulating factor (GM-CSF) during anti-leukemic therapy--a case report on the basis of a clinical phase II trial.
Topics: Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Colony-Stimulating Factors; Danazol; DNA, Neoplasm; Drug Evaluation; Granulocyte-Macrophage Colony-Stimulating Factor; Growth Substances; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Male; Tamoxifen | 1990 |
Cytochemical maturation index for the prognostication of adult acute nonlymphocytic leukaemia.
Topics: Adult; Age Factors; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cell Differentiation; Cell Survival; Danazol; Esterases; Humans; Leukemia, Myeloid, Acute; Middle Aged; Peroxidases; Prognosis; Remission Induction; Tamoxifen | 1989 |
Hormonal and non-hormonal medical therapy of benign breast disease.
Topics: Breast Diseases; Danazol; Female; Humans; Pregnadienes; Progesterone; Tamoxifen | 1989 |
[The effect of danazol and tamoxifen on endometrial hyperplasia].
Topics: Danazol; Endometrial Hyperplasia; Endometrium; Female; Humans; Middle Aged; Pregnadienes; Tamoxifen | 1989 |
Oestrogen modulators and clear cell carcinoma of vagina.
Topics: Adenocarcinoma; Adult; Aged; Danazol; Estrogens; Female; Humans; Pregnadienes; Tamoxifen; Vaginal Neoplasms | 1987 |
Acute leukaemia during pregnancy.
Topics: Adult; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Danazol; Female; Humans; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Tamoxifen | 1987 |
Endocrine treatment of breast cancer: effects upon intratumoral estrone sulfate metabolism and peripheral steroid levels.
Topics: Aminoglutethimide; Breast Neoplasms; Danazol; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Drug Administration Schedule; Estrogens; Estrone; Female; Humans; Pregnadienes; Sex Hormone-Binding Globulin; Tamoxifen | 1986 |
Current status of hormonal therapy of fibrocystic breast disease.
Topics: Bromocriptine; Chronobiology Phenomena; Danazol; Female; Fibrocystic Breast Disease; Humans; Lynestrenol; Pregnadienes; Prolactin; Sulpiride; Tamoxifen; Thermography; Thyrotropin; Thyrotropin-Releasing Hormone; Time Factors | 1986 |
Effects of progesterone, progestogens, and danazol on the specific cortisol binding in human plasma.
Topics: Binding, Competitive; Danazol; Humans; Hydrocortisone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnadienes; Progesterone; Progestins; Tamoxifen; Transcortin | 1985 |
DNA aneuploidies in adult patients with acute myeloid leukemia. Incidence and relation to patient characteristics and morphologic subtypes.
Topics: Adolescent; Adult; Age Factors; Aged; Aminoglutethimide; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Danazol; Flow Cytometry; Humans; L-Lactate Dehydrogenase; Leukemia, Myeloid, Acute; Leukocyte Count; Middle Aged; Preleukemia; Tamoxifen | 1986 |
Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines.
Topics: Aminoglutethimide; Animals; Azasteroids; Breast Neoplasms; Cell Cycle; Cell Line; Danazol; Dexamethasone; Dihydrotestosterone; Estradiol; Flutamide; Humans; Pancreatic Neoplasms; Progesterone; Rats; Receptors, Androgen; Receptors, Estrogen; Tamoxifen | 1986 |
Response of nitrosomethylurea-induced rat mammary tumor to endocrine therapy and comparison with clinical response.
Topics: Aminoglutethimide; Androstenedione; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Danazol; Dihydrotestosterone; Female; Humans; Mammary Neoplasms, Experimental; Menopause; Methylnitrosourea; Ovariectomy; Rats; Tamoxifen | 1986 |
[Various induction therapies in older patients with acute myeloid leukemias].
Topics: Aclarubicin; Adolescent; Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Danazol; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Leukapheresis; Leukemia, Myeloid, Acute; Male; Middle Aged; Naphthacenes; Tamoxifen | 1985 |
[Acute myelomonocytic and monoblastic leukemia with polyradicular symptoms].
Topics: Abducens Nerve; Adult; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cerebral Hemorrhage; Cerebrospinal Fluid; Cranial Nerve Diseases; Cytarabine; Danazol; Demyelinating Diseases; Facial Paralysis; Female; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Meningism; Methotrexate; Middle Aged; Spinal Nerve Roots; Tamoxifen | 1985 |
Effect of estradiol and steroid analogues on the clearance of immunoglobulin G-coated erythrocytes.
Topics: Anemia, Hemolytic, Autoimmune; Animals; Chromium Radioisotopes; Danazol; Desoxycorticosterone; Erythrocytes; Estradiol; Female; Guinea Pigs; Hot Temperature; Hydrocortisone; Immunoglobulin G; Macrophage-1 Antigen; Macrophages; Purpura, Thrombocytopenic; Receptors, Antigen, B-Cell; Receptors, Complement; Receptors, Fc; Spleen; Tamoxifen; Tetrahydrocortisone | 1985 |
[AMSA/etoposide (VP 16-213). A phase I/II study in refractory acute myeloid leukemia].
Topics: Aminoacridines; Aminoglutethimide; Amsacrine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Danazol; Drug Evaluation; Drug Resistance; Etoposide; Humans; Leukemia, Myeloid, Acute; Tamoxifen | 1985 |
Inhibition of steroid sulfatase activity by danazol.
Topics: Aminoglutethimide; Breast Neoplasms; Carcinoma; Culture Techniques; Danazol; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Estrogen Antagonists; Estrone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnadienes; Tamoxifen | 1984 |
[Case report on the hormonal aspects of the therapy of pulmonary lymphangioleiomyomatosis].
Topics: Adult; Castration; Combined Modality Therapy; Danazol; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Lymphangiomyoma; Lymphoproliferative Disorders; Tamoxifen | 1983 |
Prognostic significance of serum prolactin levels in advanced breast cancer.
Topics: Aminoglutethimide; Breast Neoplasms; Danazol; Drug Therapy, Combination; Female; Humans; Menopause; Prognosis; Prolactin; Tamoxifen | 1983 |
Assessment of response of bone metastases to systemic treatment in patients with breast cancer.
Topics: Alkaline Phosphatase; Aminoglutethimide; Antineoplastic Agents; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Calcium; Creatinine; Danazol; Doxorubicin; Drug Therapy, Combination; Female; Humans; Hydroxyproline; Radiography; Tamoxifen; Time Factors; Vincristine | 1983 |
Weight loss during therapy for advanced breast cancer.
Topics: Antineoplastic Agents; Body Weight; Breast Neoplasms; Danazol; Drug Therapy, Combination; Female; Humans; Tamoxifen | 1982 |
Tamoxifen, aminoglutethimide and danazol: effect of therapy on hormones in post-menopausal patients with breast cancer.
Topics: Aminoglutethimide; Androgens; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Danazol; Drug Therapy, Combination; Estradiol; Female; Gonadotropins, Pituitary; Hormones; Humans; Menopause; Pregnadienes; Tamoxifen | 1982 |
Estrogen activates migration potential of endometrial cancer cells through basement membrane.
Topics: Antineoplastic Agents, Hormonal; Basement Membrane; Cell Movement; Danazol; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Humans; Medroxyprogesterone Acetate; Neoplasm Invasiveness; Ovarian Neoplasms; Progesterone; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1996 |
[Complete remission in acute promyelocytic leukemia. The advantages of all-trans-retinoic acid compared to conventional chemotherapy].
Topics: Adult; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Danazol; Drug Evaluation; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mitoxantrone; Prognosis; Remission Induction; Tamoxifen; Time Factors; Tretinoin | 1994 |
Trisomy 21 as the sole clonal aberration in a patient with acute myelomonocytic leukemia with abnormal bone marrow eosinophils and extramedullary involvement.
Topics: Adult; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Danazol; Down Syndrome; Eosinophils; Humans; Leukemia, Myelomonocytic, Acute; Male; Tamoxifen | 1994 |
Mastalgia: a 3 year Australian study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Breast Diseases; Danazol; Fatty Acids, Essential; Female; gamma-Linolenic Acid; Humans; Linoleic Acids; Oenothera biennis; Pain; Pain Management; Pain Measurement; Parity; Plant Oils; Progesterone; Pyridoxine; Tamoxifen; Treatment Outcome | 1994 |
Endometrial rollerball ablation.
Topics: Antineoplastic Agents; Atrophy; Danazol; Dilatation and Curettage; Electrocoagulation; Endometrium; Estrogen Antagonists; Female; Humans; Hysteroscopy; Leuprolide; Medroxyprogesterone Acetate; Menorrhagia; Preoperative Care; Retrospective Studies; Tamoxifen; Treatment Outcome | 1996 |
Estrogen and progesterone receptor manipulations in castrated rat uterus models and the clinical adaptation.
Topics: Animals; Danazol; Disease Models, Animal; Estrogen Antagonists; Female; Luteolytic Agents; Ovariectomy; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Triptorelin Pamoate; Uterus | 1998 |
Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia.
Topics: Adult; Aged; alpha 1-Antitrypsin; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blast Crisis; Bleomycin; Bone Marrow; Cyclophosphamide; Dacarbazine; Danazol; Disease-Free Survival; Doxorubicin; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Nimustine; Peptide Fragments; Prednisone; Probability; Procarbazine; Prognosis; Proteinuria; Recurrence; Remission Induction; Reproducibility of Results; Tamoxifen; Time Factors; Vincristine | 1995 |
Comparison of tamoxifen with danazol in the management of idiopathic gynecomastia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Danazol; Estrogen Antagonists; Gynecomastia; Humans; Male; Middle Aged; Retrospective Studies; Tamoxifen; Treatment Outcome | 2000 |
Advanced age and high initial WBC influence the outcome of inv(3) (q21q26)/t(3;3) (q21;q26) positive AML.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Chromosome Inversion; Chromosomes, Human, Pair 3; Cohort Studies; Cytarabine; Danazol; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Karyotyping; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Mitoxantrone; Prognosis; Survival Analysis; Tamoxifen; Translocation, Genetic | 2007 |